A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) A61P 35/00 (2006.01) A61P 35/02 (2006.01) A61P 37/02 (2006.01) C07K 16/28 (2006.01)
Patent
CA 2436180
A combination antibody therapy for treating B cell malignancies using an immunoregulatory antibody, especially an anti-B7, anti-CD23, or anti-CD40L antibody and a B cell depleting antibody, especially anti-CD19, anti-CD20, anti-CD22 or anti-CD37 antibody is provided. Preferably, the combination therapy will comprise anti-B7 and anti-CD20 antibody administration.
L'invention porte sur une polythérapie aux anticorps destinée à traiter des cellules B malignes au moyen d'un anticorps immunorégulateur, en particulier un anticorps anti-B7, anti-CD23, ou anti-CD40L; et d'un anticorps de déplétion des cellules B, en particulier un anticorps anti-CD19, anti-CD20, anti-CD22 ou anti-CD37. De préférence, cette polythérapie consiste à administrer un anticorps anti-B7 et anti-CD20.
Hanna Nabil
Hariharan Kandasamy
Biogen Idec Inc.
Gowling Lafleur Henderson Llp
Idec Pharmaceutical Corporation
LandOfFree
Immunoregulatory antibodies and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunoregulatory antibodies and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunoregulatory antibodies and uses thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1946683